Picture of Mitsui Chemicals logo

4183 — Mitsui Chemicals News Story

0.000.00%
jp flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapSuper Stock

Japan's $12 bln chip deal courts needless strife

RPT-BREAKINGVIEWS-Japan's $12 bln chip deal courts needless strife

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Hudson Lockett

- In recent years shareholders have scored landmark victories as part of Japan’s drive to improve corporate governance and protect minority shareholders. Then there is $4.3 billion Mitsui Chemicals’ 4183.T punchy 1.84 trillion yen, or $11.5 billion, debt-soaked acquisition of chip-materials firm JSR, meant to enhance the global competitiveness of the country's supply chains. Yet shareholders have plenty to dislike about the transaction, setting up an unnecessary conflict between efforts to boost returns and Tokyo’s desire for new national champions.

The deal unveiled last week entails 200 billion yen ($1.3 billion) in financing from the Development Bank of Japan and 150 billion yen in equity issuance by Mitsui, with the remaining 1.2 trillion covered by debt and mezzanine financing. That's on top of the buyer's 876 billion yen in outstanding debt at the end of June, plus 448 billion yen of interest-bearing debt and other items taken on from JSR. Mitsui says the deal will push its net debt to more than 4 times EBITDA, while Mo Aziz, an analyst who publishes with SmartKarma, reckons the actual ratio will be close to 6. Worse, since the buyer will acquire JSR’s shares from seller JIC for cash it can probably proceed with a simple nod of approval from the board, sidestepping the need for a shareholder vote.

Minority owners including activist fund Aviva could still challenge the deal, though. With a 3% stake, for instance, they can call for an extraordinary general meeting to hold a simple majority vote on whether to demand the board halt the transaction. Opponents could even argue the deal precipitates a fundamental change in business that warrants altering the firm’s articles of incorporation, requiring two-thirds approval.

In either case, that the DBJ is helping finance the deal suggests Tokyo backs the transaction. The buyer’s new ambitions “to transform itself into a Japan-originated global specialty company” also draw heavily on the language of Prime Minister Sanae Takaichi’s investment-led drive to establish new national champions in strategic sectors. That alone doesn’t set an ironclad precedent, but it’s a troubling indicator of how Japan's government could end up supporting more value-destructive deals in the years ahead instead.

Follow Hudson Lockett on Bluesky and X.

CONTEXT NEWS

Mitsui Chemicals announced on November 9 that it ​will acquire chipmaking-materials manufacturer JSR from state-backed fund Japan Investment Corp for 1.84 trillion yen ($11.52 billion).

Mitsui is aiming for the deal to close in the ​second half of the fiscal year which runs to the end of March 2028, "after the necessary approvals under competition law and foreign investment regulations have been obtained and other conditions precedent have been satisfied".


(Editing by Robyn Mak; Production by Aditya Srivastav)

((For previous columns by the author, Reuters customers can click on LOCKETT/ hudson.lockett@thomsonreuters.com))

Recent news on Mitsui Chemicals

See all news